Wolverine Trading, LLC Compugen LTD Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$1.75 - $2.95 $52,675 - $88,795	30,100 Added 224.63%	43,500 $112,000
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $7,102 - $26,800	13,400 New	13,400 $26,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $1.2 $10,382 - $21,480	17,900 New	17,900 $13,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $102,250 - $179,000	-25,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $9,280 - $12,832	1,600 Added 6.84%	25,000 $148,000
Q2 2021 Aug 06, 2021	BUY	$6.87 - $9.16 $44,655 - $59,540	6,500 Added 38.46%	23,400 $195,000
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $8,437 - $15,147	1,100 Added 6.96%	16,900 $138,000
Q4 2020 Feb 12, 2021	SELL	$12.07 - $17.95 $133,977 - $199,245	-11,100 Reduced 41.26%	15,800 $204,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $186,912 - $256,740	13,200 Added 96.35%	26,900 $439,000
Q2 2020 Aug 13, 2020	SELL	$6.97 - $17.12 $9,061 - $22,256	-1,300 Reduced 8.67%	13,700 $192,000
Q1 2020 May 11, 2020	BUY	$5.79 - $11.83 $86,850 - $177,450	15,000 New	15,000 $114,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.